Definitions
For the purposes of the present Implementing Decision the following definitions shall apply:
(a) sampling of domestic animals : the procedure of collecting biological material from animals at the holding by or on behalf of the Competent Authority for laboratory testing;
(b) sampling of poultry flocks : The collection of samples from the environment of a poultry flock performed by or on behalf of the Competent Authority in the framework of a programme for the control of certain zoonotic Salmonella ;
(c) test : the procedure performed on a sample in a laboratory to detect, diagnose or evaluate disease agent presence or absence, disease process or the susceptibility to a specific disease agent;
(d) tuberculin testing : The procedure of performing a tuberculin skin test as defined in Annex B point 2 to Council Directive 64/432/EEC ( 8 ) , in the framework of a bovine tuberculosis programme.
Bovine brucellosis
1. The programmes for the eradication of bovine brucellosis submitted by Spain, Croatia, Italy, Portugal and the United Kingdom are hereby approved for the period from 1 January 2014 to 31 December 2014.
2. The financial contribution by the Union:
(a)
shall be at a rate of 50 % of the unit cost defined in points 1(a) and 4(a) of Annex I for:
(i)
the sampling of domestic animals;
(ii)
rose bengal tests;
(iii)
complement fixation tests;
(b)
shall be at a rate of 50 % of the eligible costs to be incurred by each Member State referred to in paragraph 1 for:
(i)
SAT tests up to a maximum of EUR 0,25 on average per test;
(ii)
ELISA tests up to a maximum of EUR 0,5 on average per test;
(iii)
bacteriological tests up to a maximum of EUR 10 on average per test;
(iv)
purchase of vaccines up to a maximum of EUR 0,50 on average per dose;
(v)
the compensation to be paid to owners for the value of their animals slaughtered subject to those programmes up to a maximum of EUR 375 on average per animal;
(c)
and shall not exceed the following:
(i)
EUR 4 900 000 for Spain;
(ii)
EUR 150 000 for Croatia;
(iii)
EUR 2 715 000 for Italy;
(iv)
EUR 805 000 for Portugal;
(v)
EUR 1 355 000 for the United Kingdom.
Bovine tuberculosis
1. The programmes for the eradication of bovine tuberculosis submitted by Ireland, Spain, Croatia, Italy, Portugal and the United Kingdom are hereby approved for the period from 1 January 2014 to 31 December 2014.
2. The financial contribution by the Union to the Member States referred to in paragraph 1, except for Ireland:
(a)
shall be at a rate of 50 % of the unit cost defined in points 3 and 4(b) of Annex I for:
(i)
tuberculin testing;
(ii)
gamma-interferon tests;
(b)
shall be at a rate of 50 % of the eligible costs to be incurred by each Member State referred to in paragraph 1 for the cost of:
(i)
bacteriological tests up to a maximum of EUR 10 on average per test;
(ii)
the compensation to be paid to owners for the value of their animals slaughtered subject to those programmes up to a maximum of EUR 375 on average per animal;
(c)
and shall not exceed the following:
(i)
EUR 11 780 000 for Spain;
(ii)
EUR 330 000 for Croatia;
(iii)
EUR 4 570 000 for Italy;
(iv)
EUR 1 035 000 for Portugal;
(v)
EUR 31 000 000 for the United Kingdom.
3. The financial contribution by the Union to Ireland:
(a)
shall be at a rate of 50 % of the unit cost defined in point 4(b) of Annex I for gamma-interferon tests;
(b)
shall be at a rate of 50 % of the eligible costs to be incurred by Ireland for the compensation to be paid to owners for the value of their animals slaughtered subject to those programmes up to a maximum of EUR 375 on average per animal;
(c)
shall not exceed EUR 7 390 000.
Ovine and caprine brucellosis
1. The programmes for the eradication of ovine and caprine brucellosis submitted by Greece, Spain, Croatia, Italy, Cyprus, and Portugal are hereby approved for the period from 1 January 2014 to 31 December 2014.
2. The financial contribution by the Union to the Member States referred to in paragraph 1, except for Greece:
(a)
shall be at a rate of 50 % of the unit cost defined in points 1(b) and 4(c) of Annex I for:
(i)
the sampling of domestic animals;
(ii)
rose bengal tests;
(iii)
complement fixation tests;
(b)
shall be at a rate of 50 % of the eligible costs to be incurred by each Member State referred to in paragraph 1 for:
(i)
bacteriological tests up to a maximum of EUR 10 on average per test;
(ii)
the purchase of vaccines up to a maximum of EUR 0,50 on average per dose;
(iii)
the compensation to be paid to owners for the value of their animals slaughtered subject to those programmes up to a maximum of EUR 50 on average per animal;
(c)
and shall not exceed the following:
(i)
EUR 7 715 000 for Spain;
(ii)
EUR 385 000 for Croatia;
(iii)
EUR 3 925 000 for Italy;
(iv)
EUR 175 000 for Cyprus;
(v)
EUR 1 125 000 for Portugal.
3. The financial contribution by the Union for Greece:
(a)
shall be at a rate of 75 % of the unit cost defined in points 4(c) of Annex I for:
(i)
rose bengal tests;
(ii)
complement fixation tests;
(b)
shall be at a rate of 75 % of the eligible costs to be incurred for:
(i)
bacteriological tests up to a maximum of EUR 15 on average per test;
(ii)
the purchase of vaccines up to a maximum of EUR 0,75 on average per dose;
(iii)
the remuneration of private practitioners performing vaccination and sampling activities under the programme;
(iv)
the salaries of seasonal staff specially recruited for management of data on the implementation of the measures of that programme;
(c)
shall be at a rate of 50 % of the eligible costs to be incurred for the compensation to be paid to owners for the value of its animals slaughtered subject to that programme up to a maximum of EUR 50 on average per animal; and
(d)
shall not exceed EUR 3 290 000.
Bluetongue in endemic or high risk areas
1. The programmes for the eradication and monitoring of bluetongue submitted by Belgium, Bulgaria, Germany, Estonia, Greece, Spain, France, Italy, Latvia, Lithuania, Malta, Austria, Poland, Portugal, Romania, Slovenia, Slovakia and Finland are hereby approved for the period from 1 January 2014 to 31 December 2014.
2. The financial contribution by the Union:
(a)
shall be at a rate of 50 % of the unit cost defined in points 1(c) and 4(d) of Annex I for:
(i)
the sampling of domestic animals;
(ii)
ELISA tests;
(iii)
PCR tests;
(b)
shall be at a rate of 50 % of the eligible costs to be incurred by each Member State referred to in paragraph 1 for the purchase of vaccines up to a maximum of EUR 0,50 on average per dose;
(c)
shall not exceed the following:
(i)
EUR 11 000 for Belgium;
(ii)
EUR 7 000 for Bulgaria;
(iii)
EUR 70 000 for Germany;
(iv)
EUR 3 000 for Estonia;
(v)
EUR 75 000 for Greece;
(vi)
EUR 590 000 for Spain;
(vii)
EUR 170 000 for France;
(viii)
EUR 350 000 for Italy;
(ix)
EUR 15 000 for Latvia;
(x)
EUR 8 000 for Lithuania;
(xi)
EUR 5 000 for Malta;
(xii)
EUR 5 000 for Austria;
(xiii)
EUR 25 000 for Poland;
(xiv)
EUR 125 000 for Portugal;
(xv)
EUR 35 000 for Romania;
(xvi)
EUR 13 000 for Slovenia;
(xvii)
EUR 25 000 for Slovakia;
(xviii)
EUR 5 000 for Finland.
Zoonotic Salmonella
1. The annual programmes for the control of certain zoonotic Salmonella in breeding, laying and broiler flocks of Gallus gallus and in flocks of turkeys ( Meleagris gallopavo ) submitted by Bulgaria, Denmark, Germany, Estonia, Ireland, Greece, France, Croatia, Italy, Cyprus, Latvia, Luxembourg, Hungary, Malta, the Netherlands, Austria, Portugal, Romania, Slovenia, Slovakia and the United Kingdom are hereby approved for the period from 1 January 2014 to 31 December 2014.
2. The annual programme for the control of certain zoonotic Salmonella in flocks of turkeys ( Meleagris gallopavo ) submitted by Poland is hereby approved for the period from 1 January 2014 to 31 December 2014.
3. The annual programme for the control of certain zoonotic Salmonella in breeding flocks of Gallus gallus submitted by the Czech Republic is hereby approved for the period from 1 January 2014 to 31 December 2014.
4. The multiannual programmes for the control of certain zoonotic Salmonella in laying and broiler flocks of Gallus gallus and in flocks of turkeys ( Meleagris gallopavo ) submitted by the Czech Republic are hereby approved for the period from 1 January 2014 to 31 December 2016.
5. The multiannual programme for the control of certain zoonotic Salmonella in breeding, laying and broiler flocks of Gallus gallus and in flocks of turkeys ( Meleagris gallopavo ) submitted by the Spain is hereby approved for the period from 1 January 2014 to 31 December 2016.
6. The multiannual programme for the control of certain zoonotic Salmonella in breeding, laying and broiler flocks of Gallus gallus submitted by Poland is hereby approved for the period from 1 January 2014 to 31 December 2016.
7. The multiannual programme for the control of certain zoonotic Salmonella in breeding and laying flocks of Gallus gallus submitted by Belgium is hereby approved for the period from 1 January 2014 to 31 December 2019.
8. The financial contribution by the Union for the year 2014:
(a)
shall be at a rate of 50 % of the unit cost defined in points 2 and 4(e) of Annex I for:
(i)
the sampling of poultry flocks;
(ii)
bacteriological tests;
(iii)
serotyping tests;
(iv)
tests to verify the efficacy of disinfection;
(v)
tests for the detection of antimicrobials;
(b)
shall be at a rate of 50 % of the eligible costs to be incurred by each Member State referred to in paragraphs 1 to 7 for:
(i)
purchase of vaccine up to a maximum of EUR 0,05 on average per dose;
(ii)
the compensation to be paid to owners for the value of:
—
the culled breeding birds of Gallus gallus up to a maximum of EUR 4 on average per bird,
—
the culled laying birds of Gallus gallus up to a maximum of EUR 2,20 on average per bird,
—
the culled parent breeding turkey birds of Meleagris gallopavo up to a maximum of EUR 12 on average per bird,
—
the destroyed hatching eggs of parent breeding Gallus gallus up to a maximum of EUR 0,20 on average per egg,
—
the destroyed table eggs of Gallus gallus up to a maximum of EUR 0,04 on average per egg,
—
the destroyed hatching eggs of parent breeding Meleagris gallopavo up to a maximum of EUR 0,40 on average per egg;
(c)
and shall not exceed the following:
(i)
EUR 1 070 000 for Belgium;
(ii)
EUR 50 000 for Bulgaria;
(iii)
EUR 175 000 for the programme of the Czech Republic referred to in paragraph 3;
(iv)
EUR 710 000 for the programme of the Czech Republic referred to in paragraph 4;
(v)
EUR 90 000 for Denmark;
(vi)
EUR 1 335 000 for Germany;
(vii)
EUR 20 000 for Estonia;
(viii)
EUR 25 000 for Ireland;
(ix)
EUR 620 000 for Greece;
(x)
EUR 760 000 for Spain;
(xi)
EUR 860 000 for France;
(xii)
EUR 160 000 for Croatia;
(xiii)
EUR 550 000 for Italy;
(xiv)
EUR 95 000 for Cyprus;
(xv)
EUR 240 000 for Latvia;
(xvi)
EUR 10 000 for Luxembourg;
(xvii)
EUR 1 940 000 for Hungary;
(xviii)
EUR 30 000 for Malta;
(xix)
EUR 2 700 000 for the Netherlands;
(xx)
EUR 1 190 000 for Austria;
(xxi)
EUR 20 000 for the programme of Poland referred to in paragraph 2;
(xxii)
EUR 2 610 000 for the programme of Poland referred to in paragraph 6;
(xxiii)
EUR 35 000 for Portugal;
(xxiv)
EUR 1 170 000 for Romania;
(xxv)
EUR 35 000 for Slovenia;
(xxvi)
EUR 970 000 for Slovakia;
(xxvii)
EUR 40 000 for United Kingdom.
Classical swine fever
1. The programmes for the control and monitoring of Classical swine fever submitted by Bulgaria, Germany, France, Croatia, Latvia, Hungary, Romania and Slovakia are hereby approved for the period from 1 January 2014 to 31 December 2014.
2. The financial contribution by the Union:
(a)
shall be at a rate of 50 % of the unit cost defined in points 1(d) and 4(f) of Annex I for:
(i)
the sampling of domestic animals;
(ii)
ELISA tests;
(iii)
PCR tests;
(iv)
virological tests;
(b)
shall be at a rate of 50 % of the eligible costs to be incurred by each Member State referred to in paragraph 1 for:
(i)
the delivery of wild boars to the authorities for laboratory testing up to a maximum of EUR 5 on average per animal;
(ii)
the purchase of oral vaccines up to a maximum of EUR 0,50 on average per dose;
(c)
shall not exceed the following:
(i)
EUR 150 000 for Bulgaria;
(ii)
EUR 670 000 for Germany;
(iii)
EUR 15 000 for France;
(iv)
EUR 65 000 for Croatia;
(v)
EUR 295 000 for Latvia;
(vi)
EUR 40 000 for Hungary;
(vii)
EUR 1 435 000 for Romania;
(viii)
EUR 345 000 for Slovakia.
3. Notwithstanding paragraph 2 points (a) and (b), for the part of the Latvian programme that will be implemented in Belarus, the financial contribution by the Union for the year 2014 shall:
(a)
be granted only for the eligible costs of the purchase of oral vaccine baits up to a maximum of EUR 1 on average per dose;
(b)
be at the rate of 100 %; and
(c)
not exceed EUR 135 000.
Swine vesicular disease
1. The programme for the eradication of swine vesicular disease submitted by Italy is hereby approved for the period from 1 January 2014 to 31 December 2014.
2. The financial contribution by the Union:
(a)
shall be at a rate of 50 % of the unit cost defined in points 1(e) of Annex I for the sampling of domestic animals;
(b)
shall be at a rate of 50 % of the eligible costs to be incurred by Italy for:
(i)
ELISA tests up to a maximum of EUR 1 on average per test;
(ii)
PCR tests up to a maximum of EUR 5 on average per test;
(iii)
virological tests up to a maximum of EUR 10 on average per test;
(c)
shall not exceed EUR 790 000 for Italy.
Avian influenza in poultry and wild birds
1. The annual surveillance programmes for avian influenza in poultry and wild birds submitted by Belgium, Bulgaria, Denmark, Germany, Estonia, Ireland, Greece, Spain, France, Croatia, Italy, Cyprus, Latvia, Lithuania, Luxembourg, Hungary, Malta, Austria, Portugal, Romania, Slovenia, Slovakia, Finland, Sweden and the United Kingdom are hereby approved for the period from 1 January 2014 to 31 December 2014.
2. The multiannual surveillance programmes for avian influenza in poultry and wild birds submitted by the Czech Republic and Poland are hereby approved for the period from 1 January 2014 to 31 December 2016.
3. The multiannual surveillance programme for avian influenza in poultry and wild birds submitted by the Netherlands is hereby approved for the period from 1 January 2014 to 31 December 2017.
4. The financial contribution by the Union for the year 2014:
(a)
shall be at a rate of 50 % of the unit cost defined in points 1(f) and 4(g) of Annex I for:
(i)
the sampling of domestic birds;
(ii)
ELISA tests;
(iii)
agar gel immune diffusion tests;
(iv)
HI test for H5/H7;
(v)
virus isolation tests;
(vi)
PCR tests;
(b)
shall be at a rate of 50 % of the eligible costs to be incurred by each Member State referred to in paragraphs 1 to 3 for the delivery of wild birds to the authorities for laboratory testing in the framework of passive surveillance up to a maximum of EUR 5 on average per bird;
(c)
shall not exceed the following:
(i)
EUR 50 000 for Belgium;
(ii)
EUR 25 000 for Bulgaria;
(iii)
EUR 20 000 for Czech Republic;
(iv)
EUR 50 000 for Denmark;
(v)
EUR 55 000 for Germany;
(vi)
EUR 5 000 for Estonia;
(vii)
EUR 70 000 for Ireland;
(viii)
EUR 15 000 for Greece;
(ix)
EUR 65 000 for Spain;
(x)
EUR 120 000 for France;
(xi)
EUR 75 000 for Croatia;
(xii)
EUR 905 000 for Italy;
(xiii)
EUR 20 000 for Cyprus;
(xiv)
EUR 20 000 for Latvia;
(xv)
EUR 10 000 for Lithuania;
(xvi)
EUR 10 000 for Luxembourg;
(xvii)
EUR 160 000 for Hungary;
(xviii)
EUR 5 000 for Malta;
(xix)
EUR 160 000 for the Netherlands;
(xx)
EUR 25 000 for Austria;
(xxi)
EUR 95 000 for Poland;
(xxii)
EUR 25 000 for Portugal;
(xxiii)
EUR 260 000 for Romania;
(xxiv)
EUR 45 000 for Slovenia;
(xxv)
EUR 25 000 for Slovakia;
(xxvi)
EUR 40 000 for Finland;
(xxvii)
EUR 30 000 for Sweden;
(xxviii)
EUR 135 000 for the United Kingdom.
Transmissible spongiform encephalopathies
1. The programmes for the monitoring and eradication of certain transmissible spongiform encephalopathies (TSE), submitted by Belgium, Bulgaria, the Czech Republic, Denmark, Germany, Estonia, Ireland, Spain, France, Croatia, Italy, Cyprus, Latvia, Lithuania, Hungary, Malta, the Netherlands, Austria, Poland, Portugal, Romania, Slovenia, Slovakia, Finland and Sweden are hereby approved for the period from 1 January 2014 to 31 December 2014.
2. The multiannual programmes for the monitoring and eradication of certain transmissible spongiform encephalopathies, submitted by Greece and Luxembourg are hereby approved for the period from 1 January 2014 to 31 December 2015.
3. The multiannual programme for the monitoring and eradication of certain transmissible spongiform encephalopathies, submitted by the United Kingdom is hereby approved for the period from 1 January 2014 to 31 December 2018.
4. The financial contribution by the Union:
(a)
shall be at a rate of 100 % of the unit cost defined in point 4(h) of Annex I for:
(i)
rapid tests on bovine animals, performed to fulfil the requirements of Article 12 paragraph 2 and Annex III Chapter A Part I points 2.1 and 3 to Regulation (EC) No 999/2001;
(ii)
rapid tests on bovine animals performed to fulfil the requirements of Annex III Chapter A Part I points 2.2 to Regulation (EC) No 999/2001, under the programmes of Bulgaria, Croatia and Romania or under the programmes of other Member States referred to in paragraphs 1 to 3 on bovine animals originating from Member States not included in the Annex to Commission Decision 2009/719/EC ( 9 ) or third countries;
(iii)
rapid tests on ovine and caprine animals:
—
in accordance with the requirements of Article 12 paragraph 2, Annex III Chapter A Part II point 5 and Annex VII to Regulation (EC) No 999/2001,
—
up to the number necessary to fulfil the minimum requirements of Annex III Chapter A Part II points 2 and 3;
(iv)
primary molecular discriminatory tests to perform as referred to in point 3(2)(c)(i) of Chapter C of Annex X to Regulation (EC) No 999/2001;
(b)
shall be at a rate of 75 % of the unit cost defined in point 4(h) of Annex I for rapid tests on bovine animals, performed to fulfil the requirements of Annex III Chapter A Part I point 2.2 to Regulation (EC) No 999/2001, not falling under paragraph (a)(ii);
(c)
shall be at a rate of 100 % of the eligible costs to be incurred by each Member State referred to paragraphs 1 to 3 for:
(i)
confirmatory tests, other than rapid tests, as referred to in Annex X Chapter C to Regulation (EC) No 999/2001 up to a maximum of EUR 50 on average per test;
(ii)
genotyping tests up to a maximum of EUR 6 on average per test;
(d)
shall be at a rate of 50 % of the cost incurred by each Member State for the compensation of the owners of animals:
—
bovines culled and destroyed up to a maximum of EUR 500 on average per animal,
—
sheep and goats culled and destroyed up to a maximum of EUR 70 on average per animal,
—
sheep and goats compulsorily slaughtered in accordance with Annex VII, Chapter B, point 2.2.2(b) and (c) to Regulation (EC) No 999/2001 up to a maximum of EUR 50 on average per animal; and
(e)
shall not exceed the following:
(i)
EUR 260 000 for Belgium;
(ii)
EUR 310 000 for Bulgaria;
(iii)
EUR 250 000 for the Czech Republic;
(iv)
EUR 235 000 for Denmark;
(v)
EUR 2 390 000 for Germany;
(vi)
EUR 45 000 for Estonia;
(vii)
EUR 660 000 for Ireland;
(viii)
EUR 1 355 000 for Greece;
(ix)
EUR 1 525 000 for Spain;
(x)
EUR 7 615 000 for France;
(xi)
EUR 2 115 000 for Italy;
(xii)
EUR 355 000 for Croatia;
(xiii)
EUR 1 060 000 for Cyprus;
(xiv)
EUR 65 000 for Latvia;
(xv)
EUR 55 000 for Lithuania;
(xvi)
EUR 30 000 for Luxembourg;
(xvii)
EUR 660 000 for Hungary;
(xviii)
EUR 15 000 for Malta;
(xix)
EUR 435 000 for the Netherlands;
(xx)
EUR 345 000 for Austria;
(xxi)
EUR 1 220 000 for Poland;
(xxii)
EUR 475 000 for Portugal;
(xxiii)
EUR 1 675 000 for Romania;
(xxiv)
EUR 115 000 for Slovenia;
(xxv)
EUR 170 000 for Slovakia;
(xxvi)
EUR 100 000 for Finland;
(xxvii)
EUR 105 000 for Sweden;
(xxviii)
EUR 1 475 000 for the United Kingdom.
Rabies
1. The annual programmes for the eradication of rabies submitted by Bulgaria, Estonia, Italy, Lithuania, Hungary, Poland, Romania and Slovakia are hereby approved for the period from 1 January 2014 to 31 December 2014.
2. The multiannual programme for the eradication of rabies submitted by Greece is hereby approved for the period from 1 January 2014 to 31 December 2015.
3. The multiannual programmes for the eradication of rabies submitted by Latvia and Finland are hereby approved for the period from 1 January 2014 to 31 December 2016.
4. The multiannual programme for the eradication of rabies submitted by Croatia is hereby approved for the period from 1 January 2014 to 31 December 2018.
5. The multiannual programme for the eradication of rabies submitted by Slovenia is hereby approved for the period from 1 January 2014 to 31 December 2019.
6. The financial contribution by the Union for the year 2014:
(a)
shall be at a rate of 75 % of the unit cost defined in point 4(i) of Annex I for:
(i)
fluorescent antibody tests (FAT);
(ii)
serological tests;
(b)
shall be at a rate of 75 % of the eligible costs to be incurred by each Member State referred to in paragraph 1 for:
(i)
the delivery of wild animals to the authorities for laboratory testing up to a maximum of EUR 10 on average per animal;
(ii)
tests for the detection of biomarker up to a maximum of EUR 7,50 on average per test;
(iii)
the isolation and characterisation of rabies virus up to a maximum of EUR 30 on average per investigation;
(iv)
the titration of the virus contained a sample of vaccine baits up to a maximum of EUR 75 on average per sample of vaccine baits tested;
(v)
the purchase of oral vaccine baits up to a maximum of EUR 0,60 on average per bait;
(vi)
the distribution of oral vaccine baits up to a maximum of 0,35 on average per bait;
(c)
shall not exceed the following:
(i)
EUR 1 790 000 for Bulgaria;
(ii)
EUR 3 210 000 for Greece;
(iii)
EUR 510 000 for Estonia;
(iv)
EUR 165 000 for Italy;
(v)
EUR 1 700 000 for Croatia;
(vi)
EUR 1 225 000 for Latvia;
(vii)
EUR 2 600 000 for Lithuania;
(viii)
EUR 1 970 000 for Hungary;
(ix)
EUR 7 470 000 for Poland;
(x)
EUR 5 500 000 for Romania;
(xi)
EUR 800 000 for Slovenia;
(xii)
EUR 285 000 for Slovakia;
(xiii)
EUR 250 000 for Finland.
7. Notwithstanding paragraphs 6 (a) and (b), for the part of the Estonian, Latvian, Lithuanian, Polish and Finnish programmes that will be implemented outside these Member States’ territories, the financial contribution by the Union for the year 2014 shall:
(a)
be granted only for the eligible costs of the purchase and of the distribution of oral vaccine baits;
(b)
be at the rate of 100 %; and
(c)
not exceed:
(i)
EUR 110 000 for the part of the Estonian programme implemented in the Russian Federation;
(ii)
EUR 475 000 for the part of the Latvian programme implemented in Belarus;
(iii)
EUR 1 570 000 for the part of the Lithuanian programme implemented in Belarus;
(iv)
EUR 1 500 000 for the part of the Polish programme implemented in Ukraine;
(v)
EUR 660 000 for the part of the Polish programme implemented in Belarus;
(vi)
EUR 95 000 for the part of the Finnish programme implemented in the Russian Federation.
8. The maximum of the eligible costs to be reimbursed for the costs referred to in paragraph 7 shall on average not exceed for the purchase and the distribution of oral vaccine baits EUR 0,95 on average per dose.
9. Notwithstanding the provisions of Article 13(2) for the programmes referred to under the current article:
(a)
the Commission, upon the request of the concerned Member State, may pay an advance of up to 60 % of the specified maximum amount within the 3 months following the receipt of the request;
(b)
eligible costs referred to in paragraph 7 shall be eligible if paid by the authorities of the third country in the territory of which the activities have been implemented and a final report and payment request has been submitted to the concerned Member State.
African swine fever
1. A financial contribution to Italy for the implementation of reinforced control measures in ports and airports of Sardinia for the prevention of the spread of African swine fever is hereby approved for the period from 1 January 2014 to 31 December 2014.
2. The financial contribution by the Union:
(a)
shall be at a rate of 50 % of the eligible costs to be incurred by Italy for the implementation of the measures referred to in paragraph 1;
(b)
shall not exceed EUR 50 000.
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.
